Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001415889-25-012768

Director bought 6,300 shares at $13.60 ($85,691)

From the SEC's structured data for this filing

Trades in this filing

Heron Patrick J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-09 Purchase : show line 1 in the form +6,300 $13.60 $85,691 6,300 I
Open-market purchases · 6,300 sh · avg $13.60 · $85,691
Loading xslF345X05/form4-05132025_080532.xml…